Rep. Robert Bresnahan, Jr. Sells Off Shares of Keurig Dr Pepper Inc. (NASDAQ:KDP)

Posted by Defense World Staff on Jun 3rd, 2025

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of Keurig Dr Pepper Inc. (NASDAQ:KDP). In a filing disclosed on May 31st, the Representative disclosed that they had sold between $1,001 and $15,000 in Keurig Dr Pepper stock on May 15th. The trade occurred in the Representative’s “JP MORGAN BROKERAGE ACCOUNT” account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

Sold $1,001 – $15,000 in shares of Zimmer Biomet (NYSE:ZBH) on 5/15/2025.
Sold $15,001 – $50,000 in shares of Elevance Health (NYSE:ELV) on 5/15/2025.
Sold $15,001 – $50,000 in shares of PepsiCo (NASDAQ:PEP) on 5/15/2025.
Sold $1,001 – $15,000 in shares of WEC Energy Group (NYSE:WEC) on 5/15/2025.
Purchased $15,001 – $50,000 in shares of Advanced Micro Devices (NASDAQ:AMD) on 5/15/2025.
Purchased $1,001 – $15,000 in shares of Hershey (NYSE:HSY) on 5/15/2025.
Purchased $1,001 – $15,000 in shares of Kraft Heinz (NASDAQ:KHC) on 5/15/2025.
Sold $1,001 – $15,000 in shares of Exxon Mobil (NYSE:XOM) on 5/15/2025.
Sold $1,001 – $15,000 in shares of Danaher (NYSE:DHR) on 5/15/2025.
Sold $1,001 – $15,000 in shares of International Flavors & Fragrances (NYSE:IFF) on 5/15/2025.

Keurig Dr Pepper Stock Performance

Shares of NASDAQ KDP opened at $33.25 on Tuesday. The company has a current ratio of 0.53, a quick ratio of 0.36 and a debt-to-equity ratio of 0.50. The stock has a 50 day simple moving average of $34.16 and a 200-day simple moving average of $33.04. The company has a market cap of $45.16 billion, a PE ratio of 20.15, a P/E/G ratio of 2.42 and a beta of 0.52. Keurig Dr Pepper Inc. has a 12-month low of $30.12 and a 12-month high of $38.28.

Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last announced its earnings results on Thursday, April 24th. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.04. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The firm had revenue of $3.64 billion for the quarter, compared to the consensus estimate of $3.57 billion. During the same quarter in the previous year, the business earned $0.38 EPS. The firm’s revenue for the quarter was up 4.8% on a year-over-year basis. On average, equities research analysts forecast that Keurig Dr Pepper Inc. will post 1.92 EPS for the current year.

Keurig Dr Pepper Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 11th. Stockholders of record on Friday, June 27th will be issued a dividend of $0.23 per share. The ex-dividend date is Friday, June 27th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.77%. Keurig Dr Pepper’s dividend payout ratio (DPR) is presently 83.64%.

Insider Buying and Selling at Keurig Dr Pepper

In related news, Director Robert James Gamgort sold 208,000 shares of Keurig Dr Pepper stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $33.96, for a total value of $7,063,680.00. Following the transaction, the director now owns 3,054,490 shares in the company, valued at $103,730,480.40. This trade represents a 6.38% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Angela A. Stephens sold 14,500 shares of the business’s stock in a transaction on Wednesday, May 7th. The stock was sold at an average price of $34.24, for a total transaction of $496,480.00. Following the transaction, the vice president now directly owns 62,411 shares of the company’s stock, valued at approximately $2,136,952.64. This represents a 18.85% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 478,500 shares of company stock worth $16,311,560. 0.40% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

KDP has been the topic of a number of recent analyst reports. Morgan Stanley upgraded shares of Keurig Dr Pepper from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $38.00 to $40.00 in a research report on Tuesday, April 1st. Royal Bank of Canada restated an “outperform” rating and issued a $42.00 target price on shares of Keurig Dr Pepper in a research report on Tuesday, April 22nd. Piper Sandler upgraded Keurig Dr Pepper from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $35.00 to $40.00 in a research report on Wednesday, April 9th. Barclays upped their price objective on Keurig Dr Pepper from $37.00 to $38.00 and gave the company an “overweight” rating in a report on Monday, April 28th. Finally, UBS Group lifted their target price on Keurig Dr Pepper from $40.00 to $42.00 and gave the stock a “buy” rating in a report on Thursday, April 17th. Four equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Keurig Dr Pepper currently has a consensus rating of “Moderate Buy” and an average price target of $39.33.

Get Our Latest Report on KDP

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. boosted its position in Keurig Dr Pepper by 21.3% during the 1st quarter. Vanguard Group Inc. now owns 145,012,806 shares of the company’s stock worth $4,962,338,000 after acquiring an additional 25,425,644 shares during the period. Wellington Management Group LLP lifted its position in shares of Keurig Dr Pepper by 10.3% in the fourth quarter. Wellington Management Group LLP now owns 60,602,781 shares of the company’s stock worth $1,946,561,000 after purchasing an additional 5,646,179 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in shares of Keurig Dr Pepper by 36.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 54,656,384 shares of the company’s stock worth $1,755,564,000 after purchasing an additional 14,473,054 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of Keurig Dr Pepper by 108.1% during the first quarter. JPMorgan Chase & Co. now owns 38,882,672 shares of the company’s stock worth $1,330,565,000 after purchasing an additional 20,196,835 shares during the period. Finally, Geode Capital Management LLC grew its position in Keurig Dr Pepper by 8.7% during the fourth quarter. Geode Capital Management LLC now owns 24,511,039 shares of the company’s stock valued at $784,974,000 after purchasing an additional 1,962,195 shares in the last quarter. Hedge funds and other institutional investors own 93.99% of the company’s stock.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania’s 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania’s 8th Congressional District. He declared candidacy for the 2026 election.

Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

About Keurig Dr Pepper

(Get Free Report)

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.